Evidence map›Paper›PMID 31402356›Full record

ArticleThe Analyst2019

Protein corona-resistant SERS tags for live cell detection of integrin receptors.

Sian Sloan-Dennison, MaKenzie R Bevins, Brian T Scarpitti, Victoria K Sauvé, Zachary D Schultz

Open access · greenAbstract read
In one paragraph

Article in The Analyst, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Plasmonic and Photothermal Properties of Silica-Capped Gold Nanoparticle Aggregates.The journal of physical chemistry. C, Nanomaterials and interfaces · 2023
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sian Sloan-DennisonDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210, USA. Schultz.133@osu.edu.
MaKenzie R Bevins
Brian T Scarpitti
Victoria K Sauvé
Zachary D Schultz
The Ohio State University · US

Funding

Targeted TERS Investigations of Ligand-Receptor BindingR01GM109988 · NIGMS · UNIVERSITY OF NOTRE DAME · PI SCHULTZ, ZACHARY · 2015 to 2024
$3.2M
NIGMS NIH HHS R01 GM109988
6 · The paper itself

Abstract

Chemical signals are conveyed to cells through ligand-receptor binding, triggering cascades of biochemical reactions and resulting in pivotal cellular functions. These binding events are important in understanding membrane signaling and drug interactions. To probe ligand-receptor binding, surface enhanced Raman scattering (SERS) tags are a promising tool. SERS tags are plasmonic nanostructures functionalized with a protective coating, a Raman reporter molecule, and a biorecognition element. In biological fluids, native proteins have affinity for bare nanoparticles and form a protein corona. SERS tags have a protective shell which eliminates this complication. It is important to analyze ligand-receptor binding with SERS tags in live cells since cell fixatives alter protein structure, leading to spectral changes and data misinterpretation. In this study, we synthesized a novel SERS tag by creating a mixed monolayer of the small cyclic arginine-glycine-aspartic acid-phenylalanine-cysteine (RGDFC) peptide and 4-mercaptobenzonitrile (MBN) on the surface of spherical gold nanoparticles (Au NP). Au-RGDFC-MBN NP showed resistance to PC formation and were successfully detected in both fixed and living human metastatic colon cancer cells.

Indexed as

Cell Line, TumorCell SurvivalGoldHumansIntegrin alphaVbeta3Metal NanoparticlesNitrilesOligopeptidesProtein CoronaSpectrum Analysis, Ramanarginyl-glycyl-aspartic acidbenzonitrileGoldIntegrin alphaVbeta3NitrilesOligopeptidesProtein Corona

Identifiers

PMID31402356
PMCPMC6733675
OpenAlexW2964896129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.